Céline Lefève
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Céline Lefève has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Ana Marques
Prévention et promotion de la santé par des Activités Collectivisantes sur les TerritoireS, France
2 shared publications - Aude Béliard
Université Paris Descartes, France
2 shared publications - Céline Gabarro
CERIES Université de Lille Lille France
2 shared publications - François Villa
Institut La Personne en Médecine Université de Paris Paris France
2 shared publications - Livia Velpry
Institut La Personne en Médecine Université de Paris Paris France
2 shared publications - Louise Virole
URMIS Université Paris Cité Paris France
2 shared publications
Latest Publications
- Open Access
- 25 October 2025
- Published by SAGE Publications in History of the Human Sciences
- Vol. 39 (3-4) , 13-38
The medical humanities in the USA and France: Towards a comparative history
This article presents a comparative historical analysis of the development of the medical humanities in the United States and France. In the US, the field evolved through three major phases: an initial focus on human values and bioethics in the 1960s; a second phase from the 1980s emphasising culture, narrative, and transdisciplinary approaches influenced by the social anthropology of medicine and the biopsychosocial model; and a third phase, emerging in the 1990s, centred on structural forces in relation to health, exemplified by Paul Farmer's use of the concept of structural violence. In contrast, the French medical humanities, institutionalised from 2010, emerged from the integration of the humanities and social sciences (SHS) into medical education. Rooted in a tradition of critical engagement, French scholars draw heavily on the philosophy of Georges Canguilhem, particularly his vitalist conception of life as a normative struggle against limitation. The article explores how Canguilhem's influence, largely underappreciated in Anglophone contexts, offers a powerful framework for rethinking health, illness, and care. It also examines the differing receptions of Michel Foucault in both traditions, proposing a re-reading of Foucault through Canguilhem's writings. The authors argue that the French emphasis on care, normativity, and the lived experience of illness – especially through the emerging field of ‘ la philosophie du soin ’ – offers a valuable counterweight to the more institutionally critical orientation of Anglophone medical humanities. The article concludes by proposing a renewed dialogue between these traditions, grounded in a shared commitment to understanding medicine as a human, social, and philosophical practice.
- 25 October 2025
- Published by SAGE Publications in History of the Human Sciences
- Vol. 39 (3-4) , 13-38
Open AccessThe medical humanities in the USA and France: Towards a comparative history
This article presents a comparative historical analysis of the development of the medical humanities in the United States and France. In the US, the field evolved through three major phases: an initial focus on human values and bioethics in the 1960s; a second phase from the 1980s emphasising culture, narrative, and transdisciplinary approaches influenced by the social anthropology of medicine and the biopsychosocial model; and a third phase, emerging in the 1990s, centred on structural forces in relation to health, exemplified by Paul Farmer's use of the concept of structural violence. In contrast, the French medical humanities, institutionalised from 2010, emerged from the integration of the humanities and social sciences (SHS) into medical education. Rooted in a tradition of critical engagement, French scholars draw heavily on the philosophy of Georges Canguilhem, particularly his vitalist conception of life as a normative struggle against limitation. The article explores how Canguilhem's influence, largely underappreciated in Anglophone contexts, offers a powerful framework for rethinking health, illness, and care. It also examines the differing receptions of Michel Foucault in both traditions, proposing a re-reading of Foucault through Canguilhem's writings. The authors argue that the French emphasis on care, normativity, and the lived experience of illness – especially through the emerging field of ‘ la philosophie du soin ’ – offers a valuable counterweight to the more institutionally critical orientation of Anglophone medical humanities. The article concludes by proposing a renewed dialogue between these traditions, grounded in a shared commitment to understanding medicine as a human, social, and philosophical practice.
- Open Access
- 9 September 2021
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 10 (9) , e28728
COVID-19 Health Crisis and Chronic Illness: Protocol for a Qualitative Study
Background: The acute nature of the COVID-19 pandemic has put a strain on health resources that are usually dedicated to chronic illnesses. Resulting changes in care practices and networks have had major repercussions on the experience of people with chronic disorders. Objective: This paper presents the protocol of the Parcours, Associations, Réseau, Chronicité, Organisation, Usagers, Retour d’expérience, Soins (PARCOURS)-COVID study. The aim of this study is to evaluate the effects of reorganization of the health system on the usual care network of patients with chronic illness, which fosters and qualifies the quality and continuum of care provided. The first objective of this study is to document these patients’ experiences through transformations and adaptations of their network, both in the practical dimension (ie, daily life and care) and subjective dimension (ie, psychosocial experience of illness and relationship to the health system). The second objective of the study is to understand and acknowledge these reorganizations during the COVID-19 lockdown and postlockdown periods. The third objective is to produce better adapted recommendations for patients with chronic illness and value their experience for the management of future health crisis. Methods: The PARCOURS-COVID study is a qualitative and participatory research involving patient organizations as research partners and members of these organizations as part of the research team. Three group of chronic diseases have been selected regarding the specificities of the care network they mobilize: (1) cystic fibrosis and kidney disease, (2) hemophilia, and (3) mental health disorders. Four consecutive phases will be conducted, including (1) preparatory interviews with medical or associative actors of each pathology field; (2) in-depth individual interviews with patients of each pathology, analyzed using the qualitative method of thematic analysis; (3) results of both these phases will then be triangulated through interviews with members of each patient’s care ecosystem; and finally, (4) focus groups will be organized to discuss the results with research participants (ie, representatives of chronic disease associations; patients; and actors of the medical, psychosocial, and family care network) in a research-action framework. Results: The protocol study has undergone a peer review by the French National Research Agency’s scientific committee and has been approved by the research ethical committee of the University of Paris (registration number: IRB 00012020-59, June 28, 2020). The project received funding from August 2020 through April 2021. Expected results will be disseminated in 2021 and 2022. Conclusions: Our findings will better inform the stakes of the current health crisis on the management of patients with chronic illness and, more broadly, any future crisis for a population deemed to be at risk. They will also improve health democracy by supporting better transferability of knowledge between the scientific and citizen communities. International Registered Report Identifier (IRRID): DERR1-10.2196/28728
- 9 September 2021
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 10 (9) , e28728
Open AccessCOVID-19 Health Crisis and Chronic Illness: Protocol for a Qualitative Study
Background: The acute nature of the COVID-19 pandemic has put a strain on health resources that are usually dedicated to chronic illnesses. Resulting changes in care practices and networks have had major repercussions on the experience of people with chronic disorders. Objective: This paper presents the protocol of the Parcours, Associations, Réseau, Chronicité, Organisation, Usagers, Retour d’expérience, Soins (PARCOURS)-COVID study. The aim of this study is to evaluate the effects of reorganization of the health system on the usual care network of patients with chronic illness, which fosters and qualifies the quality and continuum of care provided. The first objective of this study is to document these patients’ experiences through transformations and adaptations of their network, both in the practical dimension (ie, daily life and care) and subjective dimension (ie, psychosocial experience of illness and relationship to the health system). The second objective of the study is to understand and acknowledge these reorganizations during the COVID-19 lockdown and postlockdown periods. The third objective is to produce better adapted recommendations for patients with chronic illness and value their experience for the management of future health crisis. Methods: The PARCOURS-COVID study is a qualitative and participatory research involving patient organizations as research partners and members of these organizations as part of the research team. Three group of chronic diseases have been selected regarding the specificities of the care network they mobilize: (1) cystic fibrosis and kidney disease, (2) hemophilia, and (3) mental health disorders. Four consecutive phases will be conducted, including (1) preparatory interviews with medical or associative actors of each pathology field; (2) in-depth individual interviews with patients of each pathology, analyzed using the qualitative method of thematic analysis; (3) results of both these phases will then be triangulated through interviews with members of each patient’s care ecosystem; and finally, (4) focus groups will be organized to discuss the results with research participants (ie, representatives of chronic disease associations; patients; and actors of the medical, psychosocial, and family care network) in a research-action framework. Results: The protocol study has undergone a peer review by the French National Research Agency’s scientific committee and has been approved by the research ethical committee of the University of Paris (registration number: IRB 00012020-59, June 28, 2020). The project received funding from August 2020 through April 2021. Expected results will be disseminated in 2021 and 2022. Conclusions: Our findings will better inform the stakes of the current health crisis on the management of patients with chronic illness and, more broadly, any future crisis for a population deemed to be at risk. They will also improve health democracy by supporting better transferability of knowledge between the scientific and citizen communities. International Registered Report Identifier (IRRID): DERR1-10.2196/28728
- Open Access
- 12 March 2021
- Published by JMIR Publications Inc. in JMIR Preprints
COVID-19 Health Crisis and Chronic Illness: Protocol for a Qualitative Study (Preprint)
BACKGROUND The acute nature of the COVID-19 pandemic has put a strain on health resources that are usually dedicated to chronic illnesses. Resulting changes in care practices and networks have had major repercussions on the experience of people with chronic disorders. OBJECTIVE This paper presents the protocol of the Parcours, Associations, Réseau, Chronicité, Organisation, Usagers, Retour d’expérience, Soins (PARCOURS)-COVID study. The aim of this study is to evaluate the effects of reorganization of the health system on the usual care network of patients with chronic illness, which fosters and qualifies the quality and continuum of care provided. The first objective of this study is to document these patients’ experiences through transformations and adaptations of their network, both in the practical dimension (ie, daily life and care) and subjective dimension (ie, psychosocial experience of illness and relationship to the health system). The second objective of the study is to understand and acknowledge these reorganizations during the COVID-19 lockdown and postlockdown periods. The third objective is to produce better adapted recommendations for patients with chronic illness and value their experience for the management of future health crisis. METHODS The PARCOURS-COVID study is a qualitative and participatory research involving patient organizations as research partners and members of these organizations as part of the research team. Three group of chronic diseases have been selected regarding the specificities of the care network they mobilize: (1) cystic fibrosis and kidney disease, (2) hemophilia, and (3) mental health disorders. Four consecutive phases will be conducted, including (1) preparatory interviews with medical or associative actors of each pathology field; (2) in-depth individual interviews with patients of each pathology, analyzed using the qualitative method of thematic analysis; (3) results of both these phases will then be triangulated through interviews with members of each patient’s care ecosystem; and finally, (4) focus groups will be organized to discuss the results with research participants (ie, representatives of chronic disease associations; patients; and actors of the medical, psychosocial, and family care network) in a research-action framework. RESULTS The protocol study has undergone a peer review by the French National Research Agency’s scientific committee and has been approved by the research ethical committee of the University of Paris (registration number: IRB 00012020-59, June 28, 2020). The project received funding from August 2020 through April 2021. Expected results will be disseminated in 2021 and 2022. CONCLUSIONS Our findings will better inform the stakes of the current health crisis on the management of patients with chronic illness and, more broadly, any future crisis for a population deemed to be at risk. They will also improve health democracy by supporting better transferability of knowledge between the scientific and citizen communities. CLINICALTRIAL Institutional Review Board 00012020-59 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/28728
- 12 March 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessCOVID-19 Health Crisis and Chronic Illness: Protocol for a Qualitative Study (Preprint)
BACKGROUND The acute nature of the COVID-19 pandemic has put a strain on health resources that are usually dedicated to chronic illnesses. Resulting changes in care practices and networks have had major repercussions on the experience of people with chronic disorders. OBJECTIVE This paper presents the protocol of the Parcours, Associations, Réseau, Chronicité, Organisation, Usagers, Retour d’expérience, Soins (PARCOURS)-COVID study. The aim of this study is to evaluate the effects of reorganization of the health system on the usual care network of patients with chronic illness, which fosters and qualifies the quality and continuum of care provided. The first objective of this study is to document these patients’ experiences through transformations and adaptations of their network, both in the practical dimension (ie, daily life and care) and subjective dimension (ie, psychosocial experience of illness and relationship to the health system). The second objective of the study is to understand and acknowledge these reorganizations during the COVID-19 lockdown and postlockdown periods. The third objective is to produce better adapted recommendations for patients with chronic illness and value their experience for the management of future health crisis. METHODS The PARCOURS-COVID study is a qualitative and participatory research involving patient organizations as research partners and members of these organizations as part of the research team. Three group of chronic diseases have been selected regarding the specificities of the care network they mobilize: (1) cystic fibrosis and kidney disease, (2) hemophilia, and (3) mental health disorders. Four consecutive phases will be conducted, including (1) preparatory interviews with medical or associative actors of each pathology field; (2) in-depth individual interviews with patients of each pathology, analyzed using the qualitative method of thematic analysis; (3) results of both these phases will then be triangulated through interviews with members of each patient’s care ecosystem; and finally, (4) focus groups will be organized to discuss the results with research participants (ie, representatives of chronic disease associations; patients; and actors of the medical, psychosocial, and family care network) in a research-action framework. RESULTS The protocol study has undergone a peer review by the French National Research Agency’s scientific committee and has been approved by the research ethical committee of the University of Paris (registration number: IRB 00012020-59, June 28, 2020). The project received funding from August 2020 through April 2021. Expected results will be disseminated in 2021 and 2022. CONCLUSIONS Our findings will better inform the stakes of the current health crisis on the management of patients with chronic illness and, more broadly, any future crisis for a population deemed to be at risk. They will also improve health democracy by supporting better transferability of knowledge between the scientific and citizen communities. CLINICALTRIAL Institutional Review Board 00012020-59 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/28728